GENEDX HOLDINGS (WGS)
(Real Time Quote from BATS)
$32.95 USD
+0.06 (0.18%)
Updated Aug 16, 2024 11:46 AM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
GeneDx Holdings Corp. (WGS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$42.20 | $50.00 | $32.00 | 28.31% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for GeneDx Holdings Corp. comes to $42.20. The forecasts range from a low of $32.00 to a high of $50.00. The average price target represents an increase of 28.31% from the last closing price of $32.89.
Analyst Price Targets (5 )
Broker Rating
GeneDx Holdings Corp. currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 60%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.80 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/17/2024 | Goldman Sachs | Matthew Sykes | Hold | Hold |
7/10/2024 | Craig-Hallum | William B Bonello | Not Available | Strong Buy |
6/26/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $42.20 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 149 of 253 |
Current Quarter EPS Est: | -0.19 |